Late coronary occlusion after intracoronary brachytherapy

Circulation

Volumn 100, Issue 8, 1999, Pages 789-792

  Costa, Marco A ^a   Sabaté, Manel ^a   Van Der Giessen, Wim J ^a   Kay, I Patrick ^a   Cervinka, Pavel ^a   Ligthart, Jurgen M R ^a   Serrano, Pedro ^a   Coen, Veronique L M A ^a   Levendag, Peter C ^a   Serruys, Patrick W ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Angioplasty; Radioisotopes; Thrombosis

Indexed keywords

TICLOPIDINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; ELECTRON THERAPY; FEMALE; HEALING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033600539     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.8.789     Document Type: Article

References (20)

1. De Feyter PJ, de Jaegere PP, Serruys PW. Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J. 1994;127:643-651.
2. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
3. Wilson SH, Rihal CS, Bell MR, Velianou JL, Holmes DR Jr, Berger PB. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol. 1999;83:1006-1011.
4. Teirstein PS, Massullo V, Shirish J, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarnieri EM, Steuterman S, Morris NB, Leon MB, Tripuranemi P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697-1703.
5. Teirstein PS, Massullo V, Shirish J, Russo RJ, Cloutier DA, Schatz RA, Guarnieri EM, Steuterman S, Sirkin K, Norman S, Tripuranemi P. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation. 1999;99:243-247.
6. Waksman R, White LR, Chan RC, Porrazo MS, Bass BG, Satler LF, Kent KM, Geirlach LM, Mehran R, Murphy MRM, Mintz GS, Leon MB. Intracoronary radiation therapy for patients with in-stent restenosis: 6-month follow-up of a randomized clinical study. Circulation. 1998;98(suppl I):I-651. Abstract.
7. Condado JA, Saucedo JF, Caldera C, Proctor B, Fadoul M, Walksman R. Two years angiographic evaluation after intracoronary 192 iridium in humans. Circulation. 1997;96(suppl I):I-220. Abstract.
8. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, Villoria G, Acquatella H, Crocker IR, Serung KB, Liprie SF. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation. 1997;96:727-732.
9. King SB III, Williams DO, Chougule P, Klein L, Waksman R, Hillstead R, Macdonald J, Anderberg K, Crocker IR. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation. 1998; 97:2025-2030.
10. Hillstead RA, Johnson CR, Weldom TD. The Beta Cath® system. In: Waksman R, Serruys PW, eds. Handbook of Vascular Brachytherapy. London, UK: Martin Dunitz Ltd.; 1998:41-51.
11. Raizner AE, Calfee RV. The Guidant intravascular brachytherapy system. In: Waksman R, Serruys PW, eds. Handbook of Vascular Brachytherapy. London, UK: Martin Dunitz Ltd; 1998:53-58.
12. Rozenman Y, Gilon D, Welber S, Sapoznikov D, Wexler D, Lotan C, Mosseri M, Weiss AT, Hasin Y, Gotsman MS. Total coronary artery occlusion late after successful coronary angioplasty of moderately severe lesions: incidence and clinical implications. Cardiology. 1994; 85:222-228.
13. Huber SM, Mooney JF, Madison J, Mooney MR. Use of morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68:467-471.
14. Meerkin D, Bonan R, Joyal M, Tardif JC. Intracoronary beta radiation effects on dissection resolution. J Am Coll Cardiol. 1999;33(suppl A):48A. Abstract.
15. Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR Jr. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation. 1999;99:248-253.
16. van der Giessen WJ, Serruys PW, Beusekom HMM, van Woerkens LJ, van Loon H, Soei LK, Strauss BH, Beatt KJ, Verdouw PD. Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs. Circulation. 1991;83:1788-1798.
17. Smith SC, Winters KJ, Lasala JM. Stent thrombosis in a patient receiving chemotherapy. Cathet Cardovasc Diagn. 1997;40:383-386.
18. Farb A, Tang A, Virmani R. The neointima is reduced but endothelialization is incomplete 3 months after 32P B-emitting stent placement. Circulation. 1998;98(suppl I):I-779. Abstract.
19. Laird JR, Carter AJ, Hufs WM, Hoopes TG, Farb A, Nott SH, Fischell RE, Fischell DR, Virmani R, Fischell TA. Inhibition of neointimal proliferation with low-lose irradiation from a β-particle-emitting stent. Circulation. 1996;93:529-536.
20. Marco J, Fajadet J, Doucet S, Bar O, Jordan C, Carvalo H, Robert G, Cassagneau B. Palmaz-Schatz coronary stenting: predictors of subacute thrombosis and restenosis in a single center series. Interv Cardiol Monitor. 1994;1:5-13.